The Sarcoma Letter

Home
Archive
About
New
Top
Discussion
Olaparib and Temozolomide
Later Line Treatment of Uterine LMS
 • 
Brian Schulte
July 2023
Trends in FDA Approvals for Sarcoma
Where are we going?
 • 
Brian Schulte
June 2023
Second Opinions
Getting the best information
 • 
Brian Schulte
The Cisplatin Shortage
How does it affect treatment?
 • 
Brian Schulte
How I discuss treatment of desmoid tumors
A patient-centered approach
 • 
Brian Schulte
Reflections on ASCO 2023
The need for more Randomized Controlled Trials
 • 
Brian Schulte
A few ASCO Abstracts
A small selection (there will be more)
 • 
Brian Schulte
May 2023
Doxorubicin
History and Discovery
 • 
Brian Schulte
Imatinib Side Effects
Diagnosis and Management of Common Symptoms
 • 
Brian Schulte
Chemoimmunotherapy for Sarcoma
Doxorubicin and Pembrolizumab
 • 
Brian Schulte
Diagnosis and Treatment of Conventional Chondrosarcoma
A cartilagenous neoplasm
 • 
Brian Schulte
DOG1 in the Diagnosis of GIST
About 'Discovered on GIST-1'
 • 
Brian Schulte
© 2023 Sarcoma
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great writing